Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiac Amyloidosis: later-stage trial registry
7 of 9 indexed Cardiac Amyloidosis trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 7 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Cardiac Amyloidosis: 9 US clinical trials tracked, 7 recruiting.
Cardiac Amyloidosis is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Sharmila Dorbala, running 1 of these trials.
Enrollment posture brief
Registry condition cardiac-amyloidosis
OPEN 7 | RECR 78% | LATE 3 | EARLY 1 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Colorectal Carcinoma (78% recruiting · 9 trials)
Cardiac Amyloidosis lists 7 open slots (78% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cardiac Amyloidosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cardiac Amyloidosis is recruiting above its size-band peers.
7 of 9 indexed trials (77.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cardiac Amyloidosis trials is spread across many organizations.
Sharmila Dorbala accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Cardiac Amyloidosis enrolment sits around 200 participants.
Median target enrolment is 200 among the 9 trials that report a genuine target (sentinel values excluded). 3 of those (33.3%) plan for fewer than 100 participants.
-
Cardiac Amyloidosis splits between interventional and observational designs.
5 interventional and 4 observational studies make up this index (55.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Cardiovascular Multimodality Imaging Study
Montefiore Medical Center
NCT06610019
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Columbia University
NCT06034405
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
Cedars-Sinai Medical Center
NCT05139797
Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis
Life Molecular Imaging
NCT05184088
US Benchmarking Clinical Study
eMyosound SAS
NCT07215715
Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis
Brigham and Women's Hospital
NCT05619302
CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
Wake Forest University Health Sciences
NCT06096675
Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis
Sharmila Dorbala
NCT06788535
PET/MRI Evaluation of Cardiac Amyloid
Stanford University
NCT03119558
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Cardiac Amyloidosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cardiac Amyloidosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cardiac Amyloidosis page
9 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Cardiac Amyloidosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sharmila Dorbala sponsors the most Cardiac Amyloidosis trials on record, review their full trial history before evaluating a specific study. See Sharmila Dorbala's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiac Amyloidosis condition card totals 9 registered trials; most-linked intervention 18F-Florbetaben (Neuraceq®) PET/MRI; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.